BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 18082474)

  • 1. Esophageal impedance-pH monitoring.
    Sifrim D; Fornari F
    Dig Liver Dis; 2008 Mar; 40(3):161-6. PubMed ID: 18082474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technology insight: The role of impedance testing for esophageal disorders.
    Sifrim D; Blondeau K
    Nat Clin Pract Gastroenterol Hepatol; 2006 Apr; 3(4):210-9. PubMed ID: 16582963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastroesophageal reflux monitoring: pH (catheter and capsule) and impedance.
    Hong SK; Vaezi MF
    Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):1-22, v. PubMed ID: 19232277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [24-hour esophageal impedance-ph monitoring: technical aspects, indications and results].
    Karoui S; Ben Temime H; Serghini M; Zouiten L; Boubaker J; Filali A
    Tunis Med; 2012 May; 90(5):351-6. PubMed ID: 22585640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New developments in detection of gastroesophageal reflux.
    Emerenziani S; Sifrim D
    Curr Opin Gastroenterol; 2005 Jul; 21(4):450-3. PubMed ID: 15930987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of pH-impedance testing to evaluate patients with suspected extraesophageal manifestations of gastroesophageal reflux disease.
    Malhotra A; Freston JW; Aziz K
    J Clin Gastroenterol; 2008 Mar; 42(3):271-8. PubMed ID: 18223497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined pH-metry/impedance monitoring increases the diagnostic yield in patients with atypical gastroesophageal reflux symptoms.
    Bajbouj M; Becker V; Neuber M; Schmid RM; Meining A
    Digestion; 2007; 76(3-4):223-8. PubMed ID: 18174685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: complete gastro-oesophageal reflux monitoring - combined pH and impedance.
    Tutuian R; Castell DO
    Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 2():27-37. PubMed ID: 16939430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD)].
    Mönkemüller K; Neumann H; Fry LC; Kolfenbach S; Malfertheiner P
    Z Gastroenterol; 2009 Apr; 47(4):351-6. PubMed ID: 19358061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy.
    Zerbib F; Roman S; Ropert A; des Varannes SB; Pouderoux P; Chaput U; Mion F; Vérin E; Galmiche JP; Sifrim D
    Am J Gastroenterol; 2006 Sep; 101(9):1956-63. PubMed ID: 16848801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers.
    Shay S; Tutuian R; Sifrim D; Vela M; Wise J; Balaji N; Zhang X; Adhami T; Murray J; Peters J; Castell D
    Am J Gastroenterol; 2004 Jun; 99(6):1037-43. PubMed ID: 15180722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reflux monitoring: pH-metry, Bilitec and oesophageal impedance measurements.
    Pohl D; Tutuian R
    Best Pract Res Clin Gastroenterol; 2009; 23(3):299-311. PubMed ID: 19505660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic difficulties during combined multichannel intraluminal impedance and pH monitoring in patients with esophagitis or Barrett's esophagus.
    Waśko-Czopnik D; Błoński W; Paradowski L
    Adv Med Sci; 2007; 52():196-8. PubMed ID: 18217418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Will esophageal impedance replace pH monitoring?
    Vandenplas Y; Salvatore S; Vieira MC; Hauser B
    Pediatrics; 2007 Jan; 119(1):118-22. PubMed ID: 17200278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
    Weigt J; Kandulski A; Büsch F; Malfertheiner P
    Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of severity of gastroesophageal reflux disease with gastric acid secretory profile and esophageal acid exposure during nocturnal acid breakthrough: a study using 24-h dual-channel pH-metry.
    Ghoshal UC; Chourasia D; Tripathi S; Misra A; Singh K
    Scand J Gastroenterol; 2008; 43(6):654-61. PubMed ID: 18569981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of esophageal pH and multichannel intraluminal impedance testing in pediatric patients with suspected gastroesophageal reflux.
    Francavilla R; Magistà AM; Bucci N; Villirillo A; Boscarelli G; Mappa L; Leone G; Fico S; Castellaneta S; Indrio F; Lionetti E; Moramarco F; Cavallo L
    J Pediatr Gastroenterol Nutr; 2010 Feb; 50(2):154-60. PubMed ID: 19680154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multichannel intraluminal impedance and pH-metry for investigation of symptomatic gastroesophageal reflux disease.
    Weigt J; Mönkemüller K; Peitz U; Malfertheiner P
    Dig Dis; 2007; 25(3):179-82. PubMed ID: 17827936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Bravo pH capsule system.
    Kwiatek MA; Pandolfino JE
    Dig Liver Dis; 2008 Mar; 40(3):156-60. PubMed ID: 18096447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.